Conference Coverage

Inking bests suturing to mark breast tumor margins


 

FROM SSO 2016

References

The study was limited by the fact that the sham lumpectomy specimens did not contain skin or muscle, which would have allowed for more accurate margin orientation in an actual operative setting; by lack of compression of specimens with small nonpalpable lesions in containers, which further distorts specimens; and by the use of smaller lumpectomy specimens than normally obtained during cancer surgery, which could have resulted in overestimation of the discordance that might occur when larger specimens are taken, Dr. Arnaout said.

“The conclusion of our study is that specimen margin orientation really should be defined by the surgeon who knows the original shape and orientation of the tissue during surgery, and not to rely on the pathology to reorient based on some sutures placed in the centers of the specimens without defining the extent of the surface area of each of the margins,” she said.

The Canadian Cancer Society Research Institute and the Canadian Surgical Research Fund supported the study. Dr. Arnaout and coauthors reported no conflicts of interest.

Pages

Recommended Reading

VIDEO: Advice varies for chemoprevention, genetic testing in invasive breast cancer
Breast Cancer ICYMI
VIDEO: Breast cancer surgery choice depends on the individual
Breast Cancer ICYMI
Review: Use wider margins for DCIS surgery without radiotherapy
Breast Cancer ICYMI
VIDEO: Counseling patients considering contralateral prophylactic mastectomy
Breast Cancer ICYMI
VIDEO: Carefully consider impact of MRI to detect contralateral breast cancer
Breast Cancer ICYMI
VIDEO: Weighing the cost-effectiveness of contralateral risk-reducing mastectomy
Breast Cancer ICYMI
VIDEO: Treat most older women with stage I breast cancer with lumpectomy only
Breast Cancer ICYMI
Exploratory analysis provides support for Recurrence Score
Breast Cancer ICYMI
Breast density pegged as risk factor for contralateral cancer
Breast Cancer ICYMI
10-year DCIS recurrence risk dwindles with age
Breast Cancer ICYMI